17th Annual Scientific Sessions:

17th Annual Scientific Sessions:

17th Annual Scientific Sessions:

Targeting metabolic pathways to treat cardiovascular diseases

Targeting metabolic pathways to treat cardiovascular diseases

Targeting metabolic pathways to treat cardiovascular diseases

Amsterdam, The Netherlands • 23-26 June 2019

Amsterdam, The Netherlands
23-26 June 2019

Amsterdam, The Netherlands
23-26 June 2019

 

Preliminary Programme

  • Sunday, 23 June

    10:00-18:00

    Registration

    15:00-17:00

    Trainee Workshop sponsored by Elsevier
    iPS-cell-derived cardiomyocytes as model system

    Speakers:
    Robert Passier (Leiden, The Netherlands)
    Roselle Gelinas (Montreal, QC, Canada)
    Paul Wijnker (Amsterdam, The Netherlands)

    Opening Session

    18:00-18:15

    Welcome to Amsterdam

    18:15-19:15

    Keynote Lecture
    Ronald Wanders (Amsterdam, The Netherlands)
    Inborn errors of cardiac metabolic disease

    19:15-21:00

    Informal dinner reception

  • Monday, 24 June

    Session 1 — Targeting cardiac fatty acid metabolism (carnitine, PUFA, FA uptake)

    8:30-9:00

    Sander Houten (New York, NY, USA)
    Carnitine and mitochondrial (dys)function in cardiac disease

    9:00-9:30

    Ashley Cowart (Richmond, VA, USA)
    Lipotoxicity in the heart

    9:30-10:00

    2 Short talks from selected abstracts

    10:00-10:30

    Coffee break

    10:30-11:00

    Matthieu Ruiz (Montreal, Canada)
    Peroxisomal lipids and FA metabolism in cardiovascular diseases

    11:00-11:30

    Joost Luiken (Maastricht, The Netherlands)
    Vacuolar H+-ATPase as regulator of cardiac metabolism

    11:30-12:00

    2 Short talks from submitted abstracts

    12:00-13:00

    Working Lunch sponsored by QIAGEN

    Jean-Noel Billaud (QIAGEN Bioinformatics, Redwood City, CA, USA)
    title to be announced

    Session 2 — Targeting whole-body glucose metabolism: SGLT2 inhibitors for DM and HF treatment

    13:00-13:30

    Juan Badimon (New York, NY, USA)
    Beneficial effects of SGLT2 inhibitors on post-MI cardiac remodeling and metabolism in the pig

    13:30-14:00

    Michael Lehrke (Aachen, Germany)
    SGLT2 effects on cardiac metabolism and function in T2DM

    14:00-14:30

    Julian Mustroph (Regensburg, Germany)
    Empagliflozin, CamKII and GLUT1 in heart failure

    14:30-15:00

    2 Short talks from submitted abstracts

    15:00-16:30

    Poster Session I (with coffee and refreshments)

    17:30-22:00

    Discover Amsterdam:
    Canal boat tour with guide through Amsterdam
    Diner at the Waterfront Amsterdam
    Boat trip back to hotel

  • Tuesday, 25 June

    8:30-9:30

    Special Keynote Lecture/Dutch Heart Foundation Lecture
    Renée Ventura-Clapier (Paris, France)
    Gender differences in cardiovascular diseases

    9:30-10:00

    Coffee break

    Session 3 — Metabolic targets to combat cardiac IR injury

    10:00-10:30

    Lisa Heather (Oxford, UK)
    Targeting metabolism to reduce cardiac IR injury

    10:30-11:00

    Thomas Krieg (Cambridge, UK)
    Succinate dehydrogenase inhibition to reduce IR injury

    11:00-11:30

    Ioanna Andreadou (Athens, Greece)
    SGLT2 inhibitors for reducing cardiac IR injury

    11:30-12:00

    2 Short talks from selected abstracts

    12:00-13:00

    Lunch

    13:15-14:30

    Poster Session II

    Session 4 — Novel approaches for metabolic modulation

    14:30-15:00

    Thomas Pulinilkunnil (Saint John, Canada)
    Autophagy and cardiac metabolism in cardiac diseases

    15:00-15:30

    Mathias Mericskay (Paris, France)
    Nicotinamide riboside for HF treatment

    15:30-16:00

    2 Short talks from submitted abstracts

    16:00-16:30

    Coffee break

    Session 5 — The "William C. Stanley" Early Investigator Awards

    16:30-17:30

    Awardees selected by SHVM Board and meeting organisers
    (Four 10-minute lectures plus 5 minutes questions per speaker)

    19:30

    Dinner (congress venue), followed by Amsterdam DJ

  • Wednesday, 26 June

    9:00-10:00

    "William C. Stanley" Award Lecture
    Kieran Clarke (Oxford, UK)
    Ketones for the heart

    10:00-10:30

    Coffee break

    Session 6 - MitoROS as main driver of cardiac diseases?

    10:30-10:55

    Heiko Bugger (Graz, Austria)
    MitoROS in ischemia-reperfusion and remodelling

    10:55-11:20

    Jolanda van der Velden (Amsterdam, The Netherlands)
    MitoROS in hypertrophic cardiomyopathy

    11:20-11:45

    Christoph Maack (Würzburg, Germany)
    MitoROS in heart failure and diabetes

    11:45-12:15

    2 Short talks from selected abstracts

    12:15-12:30

    Invitation to SHVM 2020

    12:30-12:45

    Concluding Remarks

    12:45

    Buffet lunch and Adjourn